<DOC>
	<DOC>NCT01196923</DOC>
	<brief_summary>The purpose of this study is to confirm the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact in the treatment of atrial fibrillation.</brief_summary>
	<brief_title>Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic, Paroxysmal Atrial Fibrillation (AF) 18 to 70 Years of age Others Generally good overall health as determined by multiple criteria Willing to participate in a study Others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>